Both in Pharmaceuticals
Lisata Therapeutics vs Cellectar Biosciences INC NEW
Over the past year LSTA returned −61.9% and CLRB returned −62.5%; their daily moves had a correlation of 0.06.
LSTA −61.9% CLRB −62.5%Growth of $1, one year, split-adjusted
| Metric | LSTA | CLRB |
|---|---|---|
| Price | $1.06 | $1.24 |
| Market cap | $11.5M | $11.7M |
| Today | +3.92% | +2.48% |
| 1 month | −27.9% | −31.9% |
| 6 months | −67.1% | −51.6% |
| Year to date | −43.0% | −58.0% |
| 1 year | −62.1% | −65.5% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 114.5× | — |
| Net cash | $10.4M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 116.7% | 66.3% |
| Short % of float | 0.4% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).